The store will not work correctly when cookies are disabled.
N-(4-isopropylphenyl)-4,5-dihydrothieno[2,3-g][1,2]benzoxazole-3-carboxamide
ID: ALA4467270
PubChem CID: 20943550
Max Phase: Preclinical
Molecular Formula: C19H18N2O2S
Molecular Weight: 338.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)c1ccc(NC(=O)c2noc3c2CCc2sccc2-3)cc1
Standard InChI: InChI=1S/C19H18N2O2S/c1-11(2)12-3-5-13(6-4-12)20-19(22)17-15-7-8-16-14(9-10-24-16)18(15)23-21-17/h3-6,9-11H,7-8H2,1-2H3,(H,20,22)
Standard InChI Key: LBLXTRVIKNEYPL-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
33.9134 -12.0887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6187 -11.6759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3240 -12.0887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3285 -12.9023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1037 -13.1495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5784 -12.4886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0965 -11.8330 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
34.6187 -13.3103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9113 -12.9098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3117 -13.4588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6486 -14.1988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.4563 -14.1069 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.5109 -13.2956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2519 -12.5205 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.9692 -13.9074 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.4512 -12.3573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1962 -11.5803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3963 -11.4169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8536 -12.0291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1165 -12.8073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9158 -12.9670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0527 -11.8669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7926 -11.0922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5118 -12.4795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 9 1 0
1 2 1 0
8 4 1 0
3 2 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 3 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 1 0
10 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 1 0
22 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 338.43 | Molecular Weight (Monoisotopic): 338.1089 | AlogP: 4.88 | #Rotatable Bonds: 3 |
Polar Surface Area: 55.13 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.56 | CX Basic pKa: ┄ | CX LogP: 5.10 | CX LogD: 5.10 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.74 | Np Likeness Score: -1.63 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |